Valinject

Valinject is a Finnish medical technology company focused on the development of specialized drug delivery systems for the treatment of solid tumors. The company's flagship product is a proprietary injection device designed for the precise, controlled, and safe intratumoral administration of advanced therapeutics, including gene therapies and oncolytic viruses. By enabling direct delivery into the tumor mass, Valinject's technology aims to maximize local drug concentration and efficacy while significantly reducing systemic toxicity. The platform is particularly suited for oncology applications where conventional systemic delivery is ineffective or limited by severe side effects. Valinject collaborates with academic and industrial partners to integrate its delivery solution into clinical-stage therapeutic programs.